Lv1
40 积分 2022-08-11 加入
Structural pharmacology and mechanisms of GLP-1R signaling
18天前
已完结
Challenges and Opportunities of Emerging Mechanisms of Resistance to KRASG12C Inhibitors
1个月前
已完结
Small-molecule RNA therapeutics to target prostate cancer
1个月前
已完结
SMYD5 methylation of rpL40 links ribosomal output to gastric cancer
1个月前
已完结
Age-Related Macular Degeneration A Review
1个月前
已完结
Acetylation: a new target for protein degradation in cancer
1个月前
已完结
Beyond First-Generation KRAS Inhibitors: BBO-8520 Tests the Dual Mechanism Hypothesis
1个月前
已关闭
HER2-targeted therapies — a role beyond breast cancer
2个月前
已完结
Targeting cancer with small molecule pan-KRAS degraders
2个月前
已完结
Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial
2个月前
已完结
皖公网安备34019202002308
